nCoV.su - всё о COVID-19
The pharmaceutical company announced the authorization of the sale of drugs from coronavirus

The pharmaceutical company announced the authorization of the sale of drugs from coronavirus

Chinese pharmaceutical company said that it has received from the authorities permission to sell the drug "Favipiravir" (Favipiravir) as a potential cure for coronavirus.
Подтверждено
Источник: https://www.rbc.ru/society/16/02/2020/5e496d289a79473f7e35190a?utm_source=amp_full-link
Chinese pharmaceutical company Zhejiang Hisun Pharmaceutical said that it has received from the authorities permission to sell the drug "Favipiravir" (Favipiravir) as a potential cure for coronavirus.

The company said that it will continue clinical trials of the drug after its appearance on the market in a new way. In clinical trials of the drug was attended by 70 patients. According to initial reports, the drug has a "relatively obvious efficiency" and with a low likelihood of causing side effects. Similar tests are several remedies.

According to the world health organization, the first tests of a vaccine specifically against the virus COVID-2019 will begin on humans in four to five months. This is directly to the use of the vaccine you can go about a year and a half.